Efficacy of flutrimazole 1% powder in the treatment of tinea pedis

Mycoses

Volumn 46, Issue 3-4, 2003, Pages 126-131

  Pereda, J ^a   Noguera, X ^b   Boncompte, E ^c   Alguero M ^c   Izquierdo, I ^c   Azon A ^d   Ballestero, A ^e   Fernandez Valencia R ^f   Maestre, J R ^f   Frias J ^g   Gil, J ^h   Janes C ⁱ   Soldevila, R ⁱ   Ventura, C ^b   Pujol, R ^b   Abbad, L ^a   Ruffin, L ^a   Del Rio R ^j   Vives Vila P ^k   Pagerols, X ^k   Curco N ^k   Vives Sendra, J M ^l   Pujol, J A ^l   more..

^a Hospital Naval del Mediterraneo   (Spain)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

^c Grupo Uriach   (Spain)

^d HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^e University of Barcelona   (Spain)

^f Policlinica Nav Ntra Sra Carmen   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^h Hospital Sant Bernabe   (Spain)

ⁱ HOSPITAL GENERAL DE CATALUNYA   (Spain)

^j HOSPITAL DE L ESPERIT SANT   (Spain)

^k HOSPITAL MÚTUA DE TERRASSA   (Spain)

^l Hospital de Sant Pau i Santa Tecla   (Spain)

more..

Author keywords

Antimycotic chemotherapy; Bifonazole; Flutrimazole; Tinea pedis

Indexed keywords

BIFONAZOLE; FLUTRIMAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ECZEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POWDER; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TINEA PEDIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CLOTRIMAZOLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMIDAZOLES; MALE; POWDERS; TINEA PEDIS; TREATMENT OUTCOME; TRICHOPHYTON;

TINEA;

EID: 0038752721     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2003.00849.x     Document Type: Article

References (13)

1. Perea S, Ramos MJ, Garau M, González A, Noriega AR, del Palacio A. Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol 2000; 38: 3226-30.
2. Blake Goslen J, Kobayashi GS. Mycologic infections. In: Fitzpatrick T, Eisen AZ, Wolff K, Freedberg IM, Frank AK (eds). Dermatology in General Medicine. New York: McGraw-Hill, Inc. 1987: pp. 2193-248.
3. Izquierdo I, García-Rafanell J. Flutrimazole. Drugs Fut 1994; 19 (suppl 1): 26-35.
4. Binet O, Soto-Melo J, Delgadillo J et al. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Mycoses 1994; 37: 455-9.
5. Alomar A, Videla S, Delgadillo J et al. Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Dermatology 1995; 190: 295-300.
6. del Palacio A, Cuétara S, Izquierdo I et al. A double blind, randomised, comparative trial: flutrimazole 1% solution versus bifonazole 1% solution once daily in dermatomycoses. Mycoses 1995; 38: 395-403.
7. del Palacio A, Sanz F, Sánchez-Alor et al. Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-release® cream (1, 2 and 4%) with placebo site-release® vaginal cream. Mycoses 2000; 43: 355-65.
8. García-Rafanell J, Dronda MA, Merlos M et al. In vitro and in vivo activity studies with flutrimazole, a new imidazole derivative with antifungal activity. Arzneim Forsch Drug Res 1992; 42: 836-40.
9. Burgos A, Pontón J, Ouindós G. In vitro activity of flutrimazole against Candida species and other medically important yeasts. Rev Iberoam Micol 1993; 10: 117-9.
10. Carrillo-Muñoz AJ, Torres-Rodríguez JM. Madrenys-Brunet N, Gallach-Bau C. Microdilution susceptibility for Candida, dermatophytes and moulds using flutrimazole and clotrimazole. J Micol Med 1994; 4: 34-36.
11. Bartrolí J, Algueró M, Boncompte E, Forn J. Synthesis and antifungal activity of a series of difluorotrityl-imidazoles. Arzneim Forsch Drug Res 1992; 42: 832-5.
12. Merlos M, Vericat ML, García-Rafanell J, Forn J. Topical anti-inflammatory properties of flutrimazole, a new imidazole antifungal agent. Inflamm Res 1996; 45: 20-25.
13. Lackner TE, Clissold S, Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs 1989; 38: 204-25.